{
    "nctId": "NCT01841749",
    "briefTitle": "Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast",
    "officialTitle": "Management of Ductal Carcinoma in Situ (DCIS) or Pure Micro-invasive (DCIS-MI) Extended Breast, Axillary Node Sentinel Site (GAS) When the Diagnosis is Made by Biopsy and Treatment by Mastectomy Immediately. Descriptive Study",
    "overallStatus": "COMPLETED",
    "conditions": "Intraductal Carcinoma and Lobular Carcinoma in Situ",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "N/A",
    "enrollmentCount": 231,
    "primaryOutcomeMeasure": "Highlight the contribution of sentinel node associated with a mastectomy immediately in pure ductal carcinoma in situ (DCIS) and micro-invasive (DCIS-MI)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Older than 18 years.\n* Preoperative histological diagnosis obtained by biopsy\n* Ductal carcinoma in situ (DCIS) or pure micro-invasive (DCIS-MI)\n* Indication of mastectomy\n* Patient signed informed consent\n\nExclusion Criteria:\n\n* Age \\< 18 years\n* Infiltrating ductal carcinoma (TCC) diagnosed on biopsy\n* Pure DCIS diagnosed by lumpectomy\n* DCIS can take a conservative treatment\n* Mastectomy chosen by the patient\n* History of breast carcinoma in situ or invasive ipsilateral\n* Prior radiotherapy to the ipsilateral breast\n* History of axillary lateral homo\n* Patient who for reasons psychological, social, family or geographical could not be treated or monitored regularly according to the criteria of the study\n* Patient deprived of liberty or under guardianship",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}